Lilly faces tampering claims at COVID drug factory To view this email as a web page,
click here | | Webinar: Signaling Pathway CDx for Therapy Response Prediction Wednesday, May 26, 2021 | 11am ET / 8am PT Learn how Philips and Qiagen are using mRNA technology in OncoSignal tests to quantify functional activity of disease-relevant signal transduction pathways in any cell and tissue type. This webinar will explore applications for both preclinical disease modeling and clinical measurement of response to targeted therapies and immunotherapies. Register Now. |
Biden outlines ways to get COVID-19 vaccine to hesitant Americans as demand ebbs Eli Lilly faces employee complaints, FDA troubles at factory making COVID-19 drug: report HHS announces $250M in new funding to get COVID-19 vaccines to medically underserved areas COVID-19 tracker: Canada OKs Pfizer shot for adolescents; Biden admin supports lifting IP rights for vaccines AstraZeneca investors hit back at CEO Soriot's 2021 pay plan after COVID vaccine stumbles Adagio's COVID-19 antibody marches on to phase 2/3 after early data suggest 12 months of protection UnitedHealth Group pledges $1M to India to assist with procuring oxygen concentrators amid worsening COVID outbreak Oxford Nanopore raises $271M for sequencing tools amid IPO plans Featured Story | By Robert King President Joe Biden made a new goal of having 70% of Americans get their first dose of COVID-19 vaccine by the Fourth of July as his administration makes new strides to get shots to hard-to-reach areas. read more |
| |
|---|
|
Top Stories By Noah Higgins-Dunn Employees at Eli Lilly's New Jersey manufacturing site filed a complaint against a factory executive that claimed the exec, who is tasked with quality control, altered FDA-required documents to appear more favorable, Reuters reports. Separately, the FDA also raised quality control issues at another Lilly facility in Indianapolis in March. read more By Robert King HHS is giving out $250 million to community-based providers and organizations to get COVID-19 vaccination doses to medically underserved areas. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner Health Canada authorized the use of the Pfizer-BioNTech vaccine in adolescents aged 12 to 15, becoming one of the first countries to authorize the shot for that age group. The Biden administration will support lifting intellectual property protections for COVID-19 vaccines. And more headlines. read more By Angus Liu Another year, another revolt against AstraZeneca CEO Pascal Soriot’s compensation. Proxy advisers Glass Lewis and Institutional Shareholder Services raised concerns over AZ’s proposal to increase the maximum bonus and equities Soriot can get for the second consecutive year. read more By Annalee Armstrong Adagio Therapeutics’ COVID-19 antibody drug could provide as much as 12 months of protection against infection with the coronavirus, according to an early-stage clinical trial, supporting advancement of the therapy to phase 2/3. read more By Paige Minemyer UnitedHealth Group is donating $1 million to combat the growing COVID-19 outbreak crisis in India, building on $1.5 million sent previously to the country. read more By Andrea Park The new financing brings Oxford Nanopore’s total funding since it was founded in 2005 to more than $1.1 billion. read more |
|
